Shares of HSBC Holdings plc (LON:HSBA – Get Free Report) have been assigned a consensus rating of “Hold” from the eight analysts that are presently covering the stock, Marketbeat.com reports. Eight investment analysts have rated the stock with a hold recommendation. The average 1-year price objective among analysts that have issued a report on the stock in the last year is GBX 1,403.
Several research firms have recently weighed in on HSBA. JPMorgan Chase & Co. raised their price objective on shares of HSBC from GBX 1,380 to GBX 1,450 and gave the company a “neutral” rating in a research report on Friday, August 7th. Royal Bank Of Canada lifted their price objective on shares of HSBC from GBX 1,275 to GBX 1,375 and gave the stock a “sector perform” rating in a report on Friday, August 14th. Citigroup upped their target price on shares of HSBC from GBX 1,570 to GBX 1,640 and gave the stock a “neutral” rating in a research report on Wednesday, September 23rd. Jefferies Financial Group reissued a “hold” rating and issued a GBX 1,120 target price on shares of HSBC in a research note on Tuesday, October 27th. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a GBX 1,520 target price on shares of HSBC in a research note on Wednesday, August 5th.
View Our Latest Stock Analysis on HSBC
HSBC Price Performance
Shares of HSBC stock opened at GBX 1,275.20 on Tuesday. HSBC has a 1 year low of GBX 1,027.80 and a 1 year high of GBX 1,610. The firm has a market cap of £218.14 billion, a PE ratio of 9.11, a PEG ratio of 5.97 and a beta of 0.58. The company has a 50 day simple moving average of GBX 1,461.09 and a two-hundred day simple moving average of GBX 1,384.39.
Insider Activity
In other news, insider Elizabeth Alison Platt acquired 12,338 shares of the business’s stock in a transaction dated Thursday, October 29th. The stock was purchased at an average cost of GBX 1,297 per share, for a total transaction of £160,023.86. Insiders own 0.14% of the company’s stock.
About HSBC
See Also
- Five stocks we like better than HSBC
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for HSBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HSBC and related companies with MarketBeat.com's FREE daily email newsletter.
